Latest Headlines

  1. Aditxt, Inc. And Great Lakes Medical Laboratory Launch AditxtScore For COVID-19 In State Of Michigan As A Personalized Approach To Addressing COVID-19 Pandemic 8/11/2021

    Aditxt, Inc., a biotech innovation company with a mission to improve the health of the immune system, today announced a partnership with Great Lakes Medical Laboratory, Inc. (GLML), a full-service medical reference laboratory, to offer its AditxtScore for COVID-19 throughout the State of Michigan.

  2. New BD Benchtop Cell Analyzer Enhances Laboratory Access And Accelerates Scientific Research 8/11/2021

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a new benchtop cell analyzer that brings sophisticated flow cytometry capabilities to laboratories of all sizes.

  3. Genetron Health Tops NCCL’s External Quality Assessment Of NGS-Based Comprehensive Genomic Profiling For Solid Tumors With Full Marks 8/11/2021

    Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that its Beijing clinical laboratory has received full marks under the National Center for Clinical Laboratories’ (“NCCL”) first nationwide, external quality assessment (“EQA”) of NGS-based comprehensive genomic profiling for solid tumors.

  4. SYNLAB And IATA Partner To Facilitate Safe & Easy Travelling 8/11/2021

    SYNLAB to securely share certified COVID-19 test results with passengers directly through IATA Travel Pass, providing reliable digital proof on health status as international travel increases.

  5. PAVmed Subsidiary Lucid Diagnostics Launches First Lucid Test Centers 8/10/2021

    PAVmed Inc. (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that its majority owned subsidiary Lucid Diagnostics Inc. (“Lucid”) has begun testing patients referred by primary care physicians (“PCPs”) at three Lucid Test Centers in the Phoenix metropolitan area.

  6. StatLab Medical Products Acquires Pyramid Innovation 8/10/2021

    StatLab Medical Products (“StatLab”), a leading developer and manufacturer of diagnostic supplies and equipment for the anatomic pathology market, has acquired Pyramid Innovation (“Pyramid”).

  7. INDICAID™ COVID-19 Rapid Antigen Test Receives Emergency Use Authorization From The U.S. Food And Drug Administration 8/10/2021

    PHASE Scientific International LTD (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, today announced that its INDICAID™ COVID-19 Rapid Antigen Test (INDICAID) received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) on July 29, 2021.

  8. Fulgent Genetics And Helio Health Announce Strategic Partnership To Commercialize Early Cancer Detection Tests 8/9/2021

    Fulgent Genetics, Inc. (“Fulgent” or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, and Helio Health (“Helio”), an AI-biotechnology company developing blood-based early cancer detection tests, today announced the companies have entered into a strategic partnership to commercialize Helio’s blood-based early cancer detection tests.

  9. Dalrada Health And Vivera Pharmaceuticals Announce New Diagnostic Laboratory Joint Venture 8/9/2021

    To address the ongoing demand for COVID-19 testing and to catalyze safe return of the workforce, Dalrada Corporation is excited to announce that its subsidiary, Dalrada Health, entered into a joint venture partnership with Vivera Pharmaceutical, Inc. (“Vivera”) to form Pala Diagnostics, LLC (“Pala Diagnostics”).

  10. Thermo Fisher Scientific Updates Customizable TaqMan SARS-CoV-2 Mutation Panel To Detect Delta And Lambda Variants 8/9/2021

    Thermo Fisher Scientific, the world leader in serving science, today announced it has updated its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to detect the Delta and Lambda strains.